PTC Therapeutics (PTCT) PT Raised to $43 at Barclays
Tweet
Share
E-mail
Get Alerts PTCT Hot Sheet
Price: $69.30 -2.94%
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Rating Summary:
17 Buy, 6 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 7 | New: 5
Join SI Premium – FREE
Barclays raised its price target on PTC Therapeutics (NASDAQ: PTCT) to $43.00 (from $40.00) while maintaining a Equalweight rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Snowflake Inc. (SNOW) PT Raised to $450 at Freedom Broker
- VersaPay Corp. (VPY:CN) PT Raised to Cdn$31 at Keefe, Bruyette & Woods
- Brown Forman (BF-B) PT Raised to $30 at UBS Following Q1 Results
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
